NVO logo

Novo Nordisk A/S (NVO) Retained earnings

annual retained earnings:

$20.06B+$4.52B(+29.11%)
December 31, 2024

Summary

  • As of today (August 22, 2025), NVO annual retained earnings is $20.06 billion, with the most recent change of +$4.52 billion (+29.11%) on December 31, 2024.
  • During the last 3 years, NVO annual retained earnings has risen by +$9.05 billion (+82.19%).
  • NVO annual retained earnings is now at all-time high.

Performance

NVO Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly retained earnings:

$25.85B+$5.93B(+29.77%)
June 1, 2025

Summary

  • As of today (August 22, 2025), NVO quarterly retained earnings is $25.85 billion, with the most recent change of +$5.93 billion (+29.77%) on June 1, 2025.
  • Over the past year, NVO quarterly retained earnings has increased by +$9.75 billion (+60.55%).
  • NVO quarterly retained earnings is now at all-time high.

Performance

NVO quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

NVO Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.1%+60.5%
3 y3 years+82.2%+151.6%
5 y5 years+130.9%+185.5%

NVO Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+82.2%at high+165.4%
5 y5-yearat high+130.9%at high+185.5%
alltimeall timeat high+9505.8%at high>+9999.0%

NVO Retained earnings History

DateAnnualQuarterly
Jun 2025
-
$25.85B(+29.8%)
Mar 2025
-
$19.92B(-1.2%)
Dec 2024
$20.06B(+29.1%)
$20.15B(+10.6%)
Sep 2024
-
$18.22B(+13.2%)
Jun 2024
-
$16.10B(+12.4%)
Mar 2024
-
$14.33B(-8.0%)
Dec 2023
$15.54B(+34.3%)
$15.57B(+19.8%)
Sep 2023
-
$12.99B(+1.0%)
Jun 2023
-
$12.86B(+14.0%)
Mar 2023
-
$11.28B(-2.7%)
Dec 2022
$11.57B(+5.1%)
$11.60B(+19.1%)
Sep 2022
-
$9.74B(-5.2%)
Jun 2022
-
$10.27B(+2.8%)
Mar 2022
-
$10.00B(-8.8%)
Dec 2021
$11.01B(+5.0%)
$10.96B(+3.5%)
Sep 2021
-
$10.60B(-1.4%)
Jun 2021
-
$10.75B(+13.1%)
Mar 2021
-
$9.50B(-9.8%)
Dec 2020
$10.48B(+20.7%)
$10.54B(+11.7%)
Sep 2020
-
$9.44B(+4.2%)
Jun 2020
-
$9.05B(+11.8%)
Mar 2020
-
$8.10B(-6.5%)
Dec 2019
$8.69B(+6.2%)
$8.67B(+10.1%)
Sep 2019
-
$7.87B(-3.5%)
Jun 2019
-
$8.16B(+11.8%)
Mar 2019
-
$7.30B(-10.8%)
Dec 2018
$8.18B(+3.6%)
$8.18B(+7.3%)
Sep 2018
-
$7.62B(-3.0%)
Jun 2018
-
$7.86B(+8.9%)
Mar 2018
-
$7.22B(-8.6%)
Dec 2017
$7.90B(+20.8%)
$7.89B(+10.2%)
Sep 2017
-
$7.16B(-0.9%)
Jun 2017
-
$7.23B(+23.6%)
Mar 2017
-
$5.85B(-10.8%)
Dec 2016
$6.54B(-4.0%)
$6.56B(+6.1%)
Sep 2016
-
$6.18B(-2.8%)
Jun 2016
-
$6.36B(+15.9%)
Mar 2016
-
$5.48B(-20.0%)
Dec 2015
$6.81B(+1.6%)
$6.86B(+6.2%)
Sep 2015
-
$6.46B(+9.1%)
Jun 2015
-
$5.92B(+17.3%)
Mar 2015
-
$5.04B(-25.2%)
Dec 2014
$6.71B(-11.7%)
$6.74B(+2.0%)
Sep 2014
-
$6.60B(-0.0%)
Jun 2014
-
$6.61B(+10.8%)
Mar 2014
-
$5.96B(-21.7%)
Dec 2013
$7.60B(+10.2%)
$7.61B(+11.3%)
Sep 2013
-
$6.84B(+14.7%)
Jun 2013
-
$5.96B(+6.7%)
Mar 2013
-
$5.59B(-19.2%)
Dec 2012
$6.89B
$6.91B(+15.4%)
Sep 2012
-
$5.99B(+16.1%)
Jun 2012
-
$5.16B(-7.8%)
DateAnnualQuarterly
Mar 2012
-
$5.60B(-13.4%)
Dec 2011
$6.48B(-0.3%)
$6.47B(+1.7%)
Sep 2011
-
$6.36B(-7.5%)
Jun 2011
-
$6.88B(+9.2%)
Mar 2011
-
$6.30B(-2.2%)
Dec 2010
$6.50B(-2.1%)
$6.44B(+4.6%)
Sep 2010
-
$6.16B(+13.5%)
Jun 2010
-
$5.43B(-7.5%)
Mar 2010
-
$5.86B(-11.5%)
Dec 2009
$6.64B(+6.3%)
$6.62B(+0.3%)
Sep 2009
-
$6.60B(+5.0%)
Jun 2009
-
$6.29B(+11.6%)
Mar 2009
-
$5.63B(-10.4%)
Dec 2008
$6.24B(+3.9%)
$6.29B(+4.3%)
Sep 2008
-
$6.03B(-8.4%)
Jun 2008
-
$6.58B(+5.7%)
Mar 2008
-
$6.23B(+3.7%)
Dec 2007
$6.01B(+18.0%)
$6.00B(-1.1%)
Sep 2007
-
$6.07B(+3.9%)
Jun 2007
-
$5.84B(+14.6%)
Mar 2007
-
$5.10B(-0.0%)
Dec 2006
$5.10B(+19.5%)
$5.10B(+11.0%)
Sep 2006
-
$4.59B(-2.7%)
Jun 2006
-
$4.72B(+12.0%)
Mar 2006
-
$4.21B(-1.4%)
Dec 2005
$4.26B(+2.9%)
$4.27B(+2.3%)
Sep 2005
-
$4.18B(+2.7%)
Jun 2005
-
$4.07B(-5.8%)
Mar 2005
-
$4.32B(+3.9%)
Dec 2004
$4.14B(+15.9%)
$4.16B(+12.3%)
Sep 2004
-
$3.70B(+4.8%)
Jun 2004
-
$3.53B(+4.1%)
Mar 2004
-
$3.39B(-5.2%)
Dec 2003
$3.57B(+32.8%)
$3.58B(+33.2%)
Dec 2002
$2.69B(+36.5%)
$2.69B(+38.1%)
Dec 2001
$1.97B(-10.8%)
$1.95B(+26.3%)
Dec 2000
$2.21B(-11.0%)
$1.54B(-2.4%)
Dec 1999
$2.48B(-4.9%)
$1.58B(-30.3%)
Dec 1998
$2.61B(+22.9%)
$2.26B(+5.8%)
Dec 1997
$2.12B(-0.4%)
$2.14B(+0.9%)
Dec 1996
$2.13B(+7.3%)
$2.12B(+6.9%)
Dec 1995
$1.99B(+24.3%)
$1.98B(+24.0%)
Dec 1994
$1.60B(+27.5%)
$1.60B(+26.8%)
Dec 1993
$1.26B(+9.6%)
$1.26B(+10.2%)
Dec 1992
$1.15B(+10.5%)
$1.15B(+10.5%)
Dec 1991
$1.04B(+23.8%)
$1.04B(+23.9%)
Dec 1990
$836.90M(+35.9%)
$836.53M(+36.4%)
Dec 1989
$615.83M(+22.5%)
$613.38M(+22.0%)
Dec 1988
$502.64M(-1.5%)
$502.64M(-1.5%)
Dec 1987
$510.48M(+30.1%)
$510.48M(+30.1%)
Dec 1986
$392.49M(+22.7%)
$392.49M(+22.7%)
Dec 1985
$319.90M(+53.2%)
$319.90M(+53.2%)
Dec 1984
$208.81M
$208.81M

FAQ

  • What is Novo Nordisk A/S annual retained earnings?
  • What is the all time high annual retained earnings for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual retained earnings year-on-year change?
  • What is Novo Nordisk A/S quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly retained earnings year-on-year change?

What is Novo Nordisk A/S annual retained earnings?

The current annual retained earnings of NVO is $20.06B

What is the all time high annual retained earnings for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual retained earnings is $20.06B

What is Novo Nordisk A/S annual retained earnings year-on-year change?

Over the past year, NVO annual retained earnings has changed by +$4.52B (+29.11%)

What is Novo Nordisk A/S quarterly retained earnings?

The current quarterly retained earnings of NVO is $25.85B

What is the all time high quarterly retained earnings for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly retained earnings is $25.85B

What is Novo Nordisk A/S quarterly retained earnings year-on-year change?

Over the past year, NVO quarterly retained earnings has changed by +$9.75B (+60.55%)
On this page